Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
All medications are prescribed and monitored by our medical team to ensure safe, effective, and sustainable results
Tirzepatide is marketed under the name Mounjaro in Europe for type 2 diabetes, with an extension of marketing authorization for obesity since December 2023
Commonly reported issues include nausea , diarrhea , and constipation , especially during the initial stages of treatment or when adjusting the dosage
Additionally, the guidelines now advise the use of SGLT2 inhibitors for glycemic control in adults with type 2 diabetes who have heart failure, with reduced or preserved ejection fraction, to prevent heart failure hospitalizations (LOE A)
US$ 28.34
US$ 29.39
US$ 29.08
US$ 22.47
US$ 22.17
US$ 29.66
